METLIFE ($MET) posted quarterly earnings results for Q1 2026 on Wednesday, May 6th. The company reported earnings of $2.42 per share, beating estimates of $2.29 by $0.13. The company also reported revenue of $19,682,000,000, beating estimates of $19,671,410,440 by $10,589,560.
You can see Quiver Quantitative's $MET stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
METLIFE Hedge Fund Activity
We have seen 582 institutional investors add shares of METLIFE stock to their portfolio, and 694 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 15,099,133 shares (-74.4%) from their portfolio in Q4 2025, for an estimated $1,191,925,559
- WELLINGTON MANAGEMENT GROUP LLP removed 8,677,092 shares (-69.0%) from their portfolio in Q4 2025, for an estimated $684,969,642
- VANGUARD GROUP INC added 7,805,814 shares (+12.1%) to their portfolio in Q4 2025, for an estimated $616,190,957
- ABN AMRO BANK N.V. removed 2,101,814 shares (-96.1%) from their portfolio in Q1 2026, for an estimated $145,949,964
- BLACKROCK, INC. added 1,485,352 shares (+3.1%) to their portfolio in Q4 2025, for an estimated $117,253,686
- DODGE & COX removed 1,407,614 shares (-2.6%) from their portfolio in Q4 2025, for an estimated $111,117,049
- NORGES BANK removed 1,294,699 shares (-13.8%) from their portfolio in Q4 2025, for an estimated $102,203,539
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API.
METLIFE Government Contracts
We have seen $1,837,508 of award payments to $MET over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- HEALTH AND LIFE INSURANCE: $1,837,508
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
METLIFE Analyst Ratings
Wall Street analysts have issued reports on $MET in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keefe, Bruyette & Woods issued a "Outperform" rating on 11/11/2025
To track analyst ratings and price targets for METLIFE, check out Quiver Quantitative's $MET forecast page.
METLIFE Price Targets
Multiple analysts have issued price targets for $MET recently. We have seen 11 analysts offer price targets for $MET in the last 6 months, with a median target of $93.0.
Here are some recent targets:
- Joshua Shanker from B of A Securities set a target price of $99.0 on 04/14/2026
- Yaron Kinar from Mizuho set a target price of $93.0 on 04/13/2026
- Wesley Carmichael from Wells Fargo set a target price of $90.0 on 04/10/2026
- Thomas Gallagher from Evercore ISI Group set a target price of $96.0 on 04/09/2026
- Michael Ward from UBS set a target price of $102.0 on 04/09/2026
- Alex Scott from Barclays set a target price of $89.0 on 04/08/2026
- Ryan Krueger from Keefe, Bruyette & Woods set a target price of $87.0 on 03/26/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
Check out the Quiver Quantitative API to build on top of data on congressional stock trading, insider transactions, hedge fund moves, and more.
